These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 2420482)
1. The fibrinolytic system in man. Collen D; Lijnen HR Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482 [TBL] [Abstract][Full Text] [Related]
2. Extrinsic plasminogen activator: a new principle in fibrinolysis. Lijnen HR Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789 [TBL] [Abstract][Full Text] [Related]
3. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy. Collen D; Lijnen HR Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451 [TBL] [Abstract][Full Text] [Related]
4. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy]. Veremeenko KN; Kizim AI Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892 [TBL] [Abstract][Full Text] [Related]
5. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. Pannell R; Black J; Gurewich V J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831 [TBL] [Abstract][Full Text] [Related]
7. New approaches to thrombolytic therapy. Collen D; Lijnen HR Arteriosclerosis; 1984; 4(6):579-85. PubMed ID: 6439177 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Matsuo O; Rijken DC; Collen D Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339 [TBL] [Abstract][Full Text] [Related]
9. The fibrinolytic system in man. Reiner AP; Bell WR Crit Rev Oncol Hematol; 1984; 2(1):33-81. PubMed ID: 6085039 [TBL] [Abstract][Full Text] [Related]
10. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator. Thorsen S; Müllertz S; Suenson E; Kok P Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894 [TBL] [Abstract][Full Text] [Related]
11. Activation of the fibrinolytic system. Robison AK; Collen D Cardiol Clin; 1987 Feb; 5(1):13-9. PubMed ID: 3103919 [TBL] [Abstract][Full Text] [Related]
12. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity. Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy. Collen D J Cell Biochem; 1987 Feb; 33(2):77-86. PubMed ID: 3553213 [TBL] [Abstract][Full Text] [Related]
15. The search for the ideal thrombolytic agent. Verstraete M J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):4B-10B. PubMed ID: 2959714 [TBL] [Abstract][Full Text] [Related]
16. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis. Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809 [TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic agents and their effects on the haemostatic system. Kluft C Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542 [TBL] [Abstract][Full Text] [Related]
18. Concepts of clot lysis. Francis CW; Marder VJ Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790 [TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus. Glas-Greenwalt P; Kant KS; Allen C; Pollak VE J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000 [TBL] [Abstract][Full Text] [Related]
20. [Thrombolytics and their use]. Alessi MC; Juhan-Vague I Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]